Announcing the creation of SPIF - a non-partisan, open standard, human readable solution for uniquely identifying patent assets that is consistent with existing formats
Indian law could be the key to finding a happy medium between the interests of patent-owning pharmaceutical companies in developed countries and the needs of the public in developing countries. Read more
The Israeli Patent Office is considering amending the patent application procedure in line with that of the USPTO, so that applicants may file for a provisional patent application before filing a full patent application at a relatively low initial cost. Read more
On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more
The World Intellectual Property Organization rolled out its new timestamping solution in May and while it has a lot going for it, there are downsides too Read more
The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more
The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more
Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more
The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more
Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more
Lawsuit against the billion dollar video streaming start-up is set to keep the headline writers busy and, according to IAM analysis, could have been in the works for a long time Read more
On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more
The World Intellectual Property Organization rolled out its new timestamping solution in May and while it has a lot going for it, there are downsides too Read more
The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more
Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more
The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more
On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more
On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more
On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more
On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more
Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more
@IAM_Alerts RT @IAM_Alerts: In a split Senate, the fact that @ThomTillis, the ranking Republican member of the Judiciary Committee’s IP sub-committee,… Read more
